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Rift Valley fever: still an emerging infection after 3500 years
In the Book of Exodus, the description of the ﬁ fth plague 
of Egypt evokes a high mortality epizootic disease 
aﬀ ecting livestock such as camels, goats, and sheep. It 
is debatable whether Rift Valley fever was that biblical 
plague but it is undeniably an ancient zoonosis and its 
modern history is no less dramatic.1 The virus was ﬁ rst 
isolated in 1930 after a heavy mortality of newborn 
lambs was reported on a Merino sheep farm in Naivasha, 
Rift Valley, Kenya following unusually heavy rainfall.2 The 
associated human disease was identiﬁ ed 20 years later 
in South Africa and the relevant microbiology, clinical 
disease, ecology, and epidemiology seemed to be well 
established. This dominant disease narrative continues 
to be punctuated by multiple novel revelations 
including those reported in The Lancet Global Health by 
Maria Baudin and colleagues.3
Rift Valley fever is mainly a disease of animals with 
enzootic and epizoonotic mosquito-borne transmission 
cycles associated with corresponding endemic and 
epidemic disease in human beings based on a complex 
set of relationships between domesticated animals, the 
vectors, human behaviours, local ecology, and climate. 
The disease has long been characterised by waves of 
spontaneous abortions among domesticated animals 
and severe illness of pregnant animals and newborns 
that often heralds human infections. Human infections 
are generally subclinical or self-limited although it can 
be associated with a severe febrile illness and jaundice. 
Less than 5% develop the three major complications: 
encephalitis, retinitis and other ocular lesions, and a 
haemorrhagic fever. Transmission to human beings 
is mainly from direct or indirect contact with infected 
animals and their organs but disease has also been 
transmitted by mosquitoes and by aerosols generated in 
the laboratory. Vaccines are available for animals to limit 
the substantial economic impact of the disease.
Rift Valley fever was considered to be limited to sub-
Saharan Africa until it caused an epidemic in Egypt in 
1977. It was then considered conﬁ ned to Africa until 
an outbreak in Saudi Arabia and Yemen in 2000. Now 
it is recognised as an agricultural threat to the rest of 
the Middle East and other countries with competent 
mosquito vectors. Similarly, the disease has never 
been associated with person-to-person transmission 
including the reassuring lack of nosocomial infections 
even among health-care workers tending to patients 
with haemorrhagic fever. This dogma was altered in this 
century by two case reports of vertical transmission.4,5 
Baudin and colleagues3 extend these case reports with 
a large study that presents the unique observation of 
spontaneous abortions among febrile patients in Port 
Sudan infected with Rift Valley fever.
The authors are explicit about all the challenges of 
this study, including the lack of placental and fetal 
tissue or virus isolation for a deﬁ nitive diagnosis, 
but also the limited samples and clinical data; 
the discrepancy between the physician’s record of 
universal jaundice among these febrile patients and 
the lack of corresponding laboratory evidence; the 
lack of corresponding public health data from the 
community; and the high rate of miscarriages in 
the fever of unproven origin group in whom Rift Valley 
fever was also excluded.6 Although enviable, it might be 
premature to simply accept this association based on the 
keen observation of astute clinicians who suspected Rift 
Valley fever after noting the simultaneous outbreaks of 
fever of unproven origin associated with haemorrhagic 
disease admitted to the general hospital and of 
miscarriages among febrile patients on the obstetrics 
ward. Additional explanations might be some unique 
features of the implicated virus for which no isolates or 
full-length sequence is available, some characteristic of 
these pregnant patients, or another co-factor. However, 
none of these limitations undermines the observed 
association: we have the ﬁ rst report of an outbreak of 
human miscarriages associated with an ancient disease 
of animals that is itself associated with outbreaks of 
abortions.
The observation of spontaneous abortion due to 
Rift Valley fever is timely given the experience with two 
other emerging infections: Zika in the Americas and 
Ebola in west Africa. Zika is a sister arthropod-borne 
(arbo) virus initially isolated in Uganda and recognised 
as a minor human pathogen in the mid-1900s. Thanks 
again to a series of astute clinicians in this decade, 
Zika is associated with a severe clinical form with 
meningoencephalitis and Guillian-Barré syndrome.7 
It is also a recognised teratogen during pregnancy 
with a range of adverse pregnancy outcome and birth 
defects.8 Ebola is a haemorrhagic fever virus that is 
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almost universally fatal to pregnant women and their 
oﬀ spring with the highest risk of person-to-person 
transmission during parturition. Sexual transmission 
has also been reported for both, and transmission 
from blood transfusions and organ transplantation 
should be expected. Adverse birth outcomes have been 
associated with a number of other arboviruses and 
haemorrhagic fever viruses: dengue, West Nile virus, 
Japanese encephalitis virus, Venezuelan encephalitis 
virus, and Lassa.9
Astute clinicians play a crucial role in identifying 
emerging and re-emerging infectious diseases. The 
current pattern of identiﬁ cation of new microbes will 
likely continue or might even accelerate with climate 
disruption, weakened health systems, and more 
rapid and robust transportation networks for people, 
animals, and goods. It is incumbent on public health 
practitioners to improve the prediction and detection 
system for emerging infections to alert the health 
system and community to take preventive measures. 
Clinicians should be open to the possibility of adverse 
birth outcomes associated with emerging pathogens, 
new clinical manifestations, and alternate means of 
transmission. Women should be counselled about the 
potential risks of pregnancy loss and other adverse 
pregnancy outcomes associated with travel to areas 
with endemic viral diseases. 
It is tempting to use these data to alert pregnant 
patients who live in or travel to these areas to be 
concerned about Rift Valley fever. The lack of viral 
isolation from fetal tissue and plausible other alternative 
causes of pregnancy loss make this a bit premature. 
However, it would seem prudent to routinely 
recommend the use of an eﬀ ective mosquito repellent, 
wearing long-sleeved shirts and pants, and use of 
mosquito netting in areas with endemic and epidemic 
disease.  Additional investigation and viral isolation 
could add Rift Valley fever to the list of viral illnesses that 
cause adverse pregnancy outcomes. 
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